Hodgkin’s lymphoma in a patient with resistant schizophrenia on clozapine therapy

الملخص EN

We are reporting here a case of 31a year-old-male patient, with resistant schizophrenia, who was treated by clozapine.

After three years of treatment, he developed Hodgkin's lymphoma.

Clozapine was discontinued and chemotherapy was initiated which led to complete remission.

Unfortunately, his mental condition deteriorated, and Olanzapine was introduced to treat this relapse, which is his current prophylactic antipsychotic medication.

Little is known about Clozapine and any potential relation with malignancy if any.

We wish to report this to stimulate further research in this field.